A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells

Abstract

Analyzing memory B cell repertoires of the healthy elderly enabled Michalon et al. to develop a recombinant human antibody selective for transthyretin amyloid. This antibody removes cardiac amyloid through recruitment of phagocytic immune cells.